Schulman Associates IRB Establishes Itself in Canada
Cincinnati, OH-Oct. 27, 2009
Schulman Associates IRB (Schulman) has expanded its IRB services into Canada with an office in Toronto because of requests from clients, according to the company. The Schulman Canadian Board’s first official meeting is scheduled for this week.
For North American studies which are conducted in both the U.S. and Canada, Canadian and U.S. Board members will review the research together in order to maintain consistency.
“Our clients have asked us to provide review services in Canada. Now that our Canadian IRB is operational, Schulman can provide the same...review for Canadian research as it has provided in the U.S. for the past 26 years,” said Schulman’s CEO, John Isidor.
Schulman provides clients conducting Canadian studies with access to its WebPortal 2.0 service. WebPortal 2.0 interfaces directly with Schulman’s internal system to provide Sponsors and CROs with real-time updates on review status and timelines.
Early next year, Schulman will launch updated electronic tools to provide clients with greater access to critical review information. Schulman’s existing submission forms have been revised to comply with Canadian regulations and terminology. The revisions are minor and the forms will remain familiar to Schulman clients who have used them for U.S. studies.
French-speaking support is available for Canadian studies. Schulman’s U.S. institutional review board is fully accredited by the Association for Accreditation of Human Research Protection Programs (AAHRPP).
For more information on Schulman call Client Services at 513-761-4100 or visit www.sairb.com.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
